共 72 条
[1]
Yao JC(2008)One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States J Clin Oncol 26 3063-3072
[2]
Hassan M(2005)Endocrine tumours of the pancreas Best Pract Res Clin Gastroenterol 19 753-781
[3]
Phan A(2016)The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumours: experience from a national referral centre in the United Kingdom J Nucl Med 57 34-40
[4]
Oberg K(2002)Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies Gut 50 52-60
[5]
Eriksson B(2011)Molecular imaging with 68Ga-SSTR PET/CT and correlation to immunohistochemistry of somatostatin receptors in neuroendocrine tumours Eur J Nucl Med Mol Imaging 38 1659-1668
[6]
Skoura E(1989)Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin Lancet 1 242-244
[7]
Michopoulou S(2015)Somatostatin receptor imaging with 68Ga DOTATATE PET/CT: clinical utility, normal patterns, pearls, and pitfalls in interpretation Radiographics 35 500-516
[8]
Mohmaduvesh M(2012)Diagnostic performance of gallium-68 somatostatin receptor PET and PET/CT in patients with thoracic and gastroenteropancreatic neuroendocrine tumours: a meta-analysis Endocrine 42 80-87
[9]
Kulaksiz H(2015)Simultaneous 68Ga-DOTA-TOC PET/MRI with gadoxetate disodium in patients with neuroendocrine tumor Abdom Imaging 40 1432-1440
[10]
Eissele R(2013)Simultaneous 68Ga-DOTATOC PET/MRI in patients with gastroenteropancreatic neuroendocrine tumors: initial results Investig Radiol 48 273-279